CRINETICS PHARMACEUTICALS IN

CRNXNASDAQ

🏆 #895 by market capUS Equity

$84.96▲ $0.10 (+0.12%)

Pre-market · at close

24h▲ 0.1%

7d—

14d—

30d—

ytd▲ 82.5%

1y▲ 98.3%

🏦Market Cap

$9.01B

Small Cap

📈Revenue Growth (YoY)

2928.4%

High Growth

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

213.8x

Expensive

Otter Score

—

Insufficient data

🔭

No analyst ratings for CRNX

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.